Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.82M Sell
48,400
-1,200
-2% -$139K 0.63% 39
2025
Q4
$5.22M Buy
49,600
+2,100
+4% +$197K 0.51% 45
2025
Q3
$3.99M Buy
47,500
+14,100
+42% +$1.16M 0.46% 44
2025
Q2
$2.64M Buy
+33,400
New +$2.65M 0.33% 61

Other funds holding MRK

Westerkirk Capital's MRK Position: Q1 2026 in Review

Westerkirk Capital reduced its Merck (MRK) stake by 2.4% in Q1 2026, selling an estimated $139K and leaving 48,400 shares worth $5.82M. The position accounts for 0.63% of the portfolio, ranked #39.

Westerkirk Capital first reported a position in MRK in Q2 2025 and has held it in 4 quarters since. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Westerkirk Capital held 48,400 shares of Merck worth $5.82M as of Q1 2026.
  • Westerkirk Capital sold 1,200 Merck shares in Q1 2026, an estimated $139K.
  • Merck made up 0.63% of Westerkirk Capital's portfolio in Q1 2026, its #39 holding.
  • Westerkirk Capital first reported a position in Merck in Q2 2025 and has held it in 4 quarters since.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Westerkirk Capital's 13F filing for Q1 2026, filed 14 May 2026.